Physicopharmaceutical Characteristics of Ulinastatin Vaginal Suppositories Prepared in Hospital

  • SATAKE Kiyoshi
    Department of Pharmacy, Saitama Red Cross Hospital Clinical Pharmacy Educational Center, Nihon Pharmaceutical University
  • NAKAJIMA Takanori
    Clinical Pharmacy Educational Center, Nihon Pharmaceutical University
  • IWATA Masanori
    Department of Clinical Pharmaceutics, Yokohama College of Pharmacy
  • FUJIKAKE Yoshio
    Department of Pharmacy, Saitama Red Cross Hospital
  • KIMURA Masayuki
    Clinical Pharmacy Educational Center, Nihon Pharmaceutical University

Bibliographic Information

Other Title
  • 院内製剤ウリナスタチン膣坐剤の物理薬剤学的特性
  • インナイ セイザイ ウリナスタチンチツザザイ ノ ブツリ ヤクザイガクテキ トクセイ

Search this article

Description

We studied a locally applied vaginal preparation (vaginal suppositories) of ulinastatin (urinary trypsin inhibitor, UTI), designed to threatened premature delivery and maintain pregnancy. Witepsol S55 was chosen as the basic component of the vaginal suppositories based on the physical pharmaceutical characteristics of three kinds of hard fats. The average particle size of the UTI aqueous injection was approximately 70% as compared with that of the UTI lyophilized product, used as the base material for the preparation of UTI vaginal suppositories. We compared the physical pharmaceutical properties of UTI vaginal suppositories with water contents of 2.5%, 5.0%, and 7.5%, respectively. Preparation strength negatively correlated with the water content. The coefficient of viscosity positively correlated with the water content of the preparation. UTI vaginal suppositories with a water content of 5.0% had the highest average drug release rate on moment analysis. A comprehensive evaluation of the properties of UTI vaginal suppositories, including high strength due to disintegration resistance, the coefficient of viscosity and its influence on local retention, and drug release and its influence on the duration of effect, indicated that a 5.0% UTI aqueous solution for injection combined with Witepsol S55 as the base was the optimal formulation for the hospital preparation of vaginal suppositories.<br>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 131 (11), 1639-1644, 2011-11-01

    The Pharmaceutical Society of Japan

Citations (1)*help

See more

References(4)*help

See more

Details 詳細情報について

Report a problem

Back to top